AIMC Topic: Drug Discovery

Clear Filters Showing 911 to 920 of 1559 articles

The application of machine learning techniques to innovative antibacterial discovery and development.

Expert opinion on drug discovery
INTRODUCTION: After the initial wave of antibiotic discovery, few novel classes of antibiotics have emerged, with the latest dating back to the 1980's. Furthermore, the pace of antibiotic drug discovery is unable to keep up with the increasing preval...

Insight into potent leads for alzheimer's disease by using several artificial intelligence algorithms.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Several proteins including S-nitrosoglutathione reductase (GSNOR), complement Factor D, complement 3b (C3b) and Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK), have been demonstrated to be involved in pathogenesis pathways for Alzheimer's ...

Machine Learning on DNA-Encoded Libraries: A New Paradigm for Hit Finding.

Journal of medicinal chemistry
DNA-encoded small molecule libraries (DELs) have enabled discovery of novel inhibitors for many distinct protein targets of therapeutic value. We demonstrate a new approach applying machine learning to DEL selection data by identifying active molecul...

Chemists: AI Is Here; Unite To Get the Benefits.

Journal of medicinal chemistry
The latest developments in artificial intelligence (AI) have arrived into an existing state of creative tension between computational and medicinal chemists. At their most productive, medicinal and computational chemists have made significant progres...

Practical Applications of Deep Learning To Impute Heterogeneous Drug Discovery Data.

Journal of chemical information and modeling
Contemporary deep learning approaches still struggle to bring a useful improvement in the field of drug discovery because of the challenges of sparse, noisy, and heterogeneous data that are typically encountered in this context. We use a state-of-the...

The Study on the hERG Blocker Prediction Using Chemical Fingerprint Analysis.

Molecules (Basel, Switzerland)
Human ether-a-go-go-related gene (hERG) potassium channel blockage by small molecules may cause severe cardiac side effects. Thus, it is crucial to screen compounds for activity on the hERG channels early in the drug discovery process. In this study,...

Medicinal Chemists versus Machines Challenge: What Will It Take to Adopt and Advance Artificial Intelligence for Drug Discovery?

Journal of chemical information and modeling
The field of artificial intelligence (AI) for generative chemistry is reaching the maturity stage, shifting the focus from the novelty of the algorithms to the quality of the generated molecules. To ensure continued evolution of AI technologies, we p...

TF3P: Three-Dimensional Force Fields Fingerprint Learned by Deep Capsular Network.

Journal of chemical information and modeling
Molecular fingerprints are the workhorse in ligand-based drug discovery. In recent years, an increasing number of research papers reported fascinating results on using deep neural networks to learn 2D molecular representations as fingerprints. It is ...

Using machine learning to improve ensemble docking for drug discovery.

Proteins
Ensemble docking has provided an inexpensive method to account for receptor flexibility in molecular docking for virtual screening. Unfortunately, as there is no rigorous theory to connect the docking scores from multiple structures to measured activ...

TOP: A deep mixture representation learning method for boosting molecular toxicity prediction.

Methods (San Diego, Calif.)
At the early stages of the drug discovery, molecule toxicity prediction is crucial to excluding drug candidates that are likely to fail in clinical trials. In this paper, we presented a novel molecular representation method and developed a correspond...